The antimicrobial susceptibility of 212 Salmonella strains isolated from patients and foods was evaluated and 45% were found to be resistant to nalidixic acid. Nalidixic acid resistant strains showed a higher minimal inhibitory concentration for ciprofloxacin than sensitive strains. During the study an increase of strains with reduced susceptibility to ciprofloxacin was also observed.
However, the use of antimicrobials is necessary for immunocompromised patients, older persons and children or in cases of severe or systemic salmonellosis (3, 18) .
The more commonly used drugs for salmonellosis treatment during the last decades were ampicillin, chloramphenicol and sulphametoxazole-trimethoprim.
Growing resistance to these antimicrobials significantly reduced their use in clinical medicine and they were gradually substituted by fluoroquinolones (3, 14) .
The non-therapeutic use of fluoroquinolones in veterinary medicine, as in prophylactic supplements or growth-promoting agents, can facilitate the selection of resistant bacteria or reduce susceptibility to these antimicrobials. Thus, the use of antimicrobial agents in animals raised for human consumption is, probably, the main cause for the increase and spread of resistant Salmonella strains (1, 9, 12) .
The high prevalence of strains resistant to nalidixic acid, a 1 st generation quinolone, constitutes a public health concern since most of these strains show reduced susceptibility to fluoroquinolones, and have been associated with treatment failures (8, 15, 18 All Salmonella strains tested in the present study were susceptible to cefotaxime, chloramphenicol and ciprofloxacin.
Ninety five (45%) strains were resistant to nalidixic acid; one additional mutations are necessary to achieve resistance to fluoroquinolones such as ciprofloxacin (7, 12) . It is also known that the antimicrobial concentration reduction within the cell due to hyperexpression of the efflux pump system contributes to a heightened quinolone MIC in Salmonella spp. but is insufficient to generate high fluoroquinolone resistance levels (2, 19) . 
